Skip to content

MEDIGREX: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

MEDIGREX

BE 0465.660.871
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€198,059
2024 · €218,115-€20,056
Equity
€535,052
2024 · €336,993+€198,059
Cash
€414,934
2024 · €331,448+€83,486
Balance sheet total
€1.2m
2024 · €1.1m+€37,114

Largest movements

2024 to 2025
Assets
  • Current investments -€100,000

    down €100,000 (-100.0%), from €100,000 to €0

  • Cash +€83,486

    up €83,486 (+25.2%), from €331,448 to €414,934

    mainly Net result for the year (+€198,059) and Current investments (+€100,000)

  • Stocks and contracts +€41,624

    up €41,624 (+13.5%), from €308,249 to €349,874

  • Receivables within one year +€27,541

    up €27,541 (+17.8%), from €154,679 to €182,221

    of which Trade receivables: +€17,736

  • Tangible fixed assets -€16,339

    down €16,339 (-6.7%), from €243,043 to €226,703

    of which Furniture and vehicles: -€14,236

Equity and liabilities
  • Reserves +€198,059

    up €198,059 (+72.0%), from €274,993 to €473,052

    of which Distributable reserves: +€198,059

  • Other debts -€190,126

    down €190,126 (-29.2%), from €650,064 to €459,938

  • Trade debts +€46,383

    up €46,383 (+48.5%), from €95,724 to €142,107

  • Tax, wage and social debts -€14,123

    down €14,123 (-24.9%), from €56,833 to €42,710

    of which Taxes: -€13,903

Income statement
  • Staff costs +€52,392

    up €52,392 (+21.2%), from €247,065 to €299,457

  • Gross operating margin +€16,467

    up €16,467 (+2.8%), from €586,978 to €603,444

  • Taxes -€6,150

    down €6,150 (-8.2%), from €75,299 to €69,149

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €218,115
Gross operating margin +€16,467
Staff costs -€52,392
Depreciation +€4,777
Other operating charges -€21
Financial income +€1,621
Financial charges +€3,341
Taxes +€6,150
Result 2025 €198,059

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€1,950
Investment +€85,435
Financing €0
Cash 2024 €331,448
Net result for the year +€198,059
Depreciation +€30,904
Stocks and contracts -€41,624
Receivables within one year -€27,541
Deferred charges and accrued income -€802
Trade debts +€46,383
Tax, wage and social debts -€14,123
Other debts -€190,126
Accrued charges and deferred income -€3,078
Investment in fixed assets (net) -€14,565
Current investments +€100,000
Cash 2025 €414,934
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,145,952 €1,183,066 +€37,114 +3.2%
Fixed assets 21/28 €243,043 €226,703 -€16,339 -6.7%
Tangible fixed assets 22/27 €243,043 €226,703 -€16,339 -6.7%
Land and buildings 22 €153,633 €145,494 -€8,138 -5.3%
Plant, machinery and equipment 23 €31,119 €37,153 +€6,035 +19.4%
Furniture and vehicles 24 €58,291 €44,055 -€14,236 -24.4%
Current assets 29/58 €902,909 €956,363 +€53,454 +5.9%
Stocks and contracts in progress 3 €308,249 €349,874 +€41,624 +13.5%
Stocks 30/36 €308,249 €349,874 +€41,624 +13.5%
Amounts receivable within one year 40/41 €154,679 €182,221 +€27,541 +17.8%
Trade receivables 40 €150,744 €168,480 +€17,736 +11.8%
Other amounts receivable 41 €3,935 €13,740 +€9,805 +249.2%
Current investments 50/53 €100,000 €0 -€100,000 -100.0%
Cash at bank and in hand 54/58 €331,448 €414,934 +€83,486 +25.2%
Deferred charges and accrued income 490/1 €8,532 €9,335 +€802 +9.4%
Total equity and liabilities 10/49 €1,145,952 €1,183,066 +€37,114 +3.2%
Equity 10/15 €336,993 €535,052 +€198,059 +58.8%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €274,993 €473,052 +€198,059 +72.0%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Distributable reserves 133 €268,793 €466,852 +€198,059 +73.7%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €808,958 €648,014 -€160,944 -19.9%
Amounts payable within one year 42/48 €802,621 €644,755 -€157,866 -19.7%
Trade debts 44 €95,724 €142,107 +€46,383 +48.5%
Suppliers 440/4 €95,724 €142,107 +€46,383 +48.5%
Taxes, remuneration and social security 45 €56,833 €42,710 -€14,123 -24.9%
Taxes 450/3 €15,299 €1,397 -€13,903 -90.9%
Remuneration and social security 454/9 €41,533 €41,313 -€220 -0.5%
Other amounts payable 47/48 €650,064 €459,938 -€190,126 -29.2%
Accrued charges and deferred income 492/3 €6,338 €3,259 -€3,078 -48.6%
Remuneration, social security and pensions 62 €247,065 €299,457 +€52,392 +21.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €35,681 €30,904 -€4,777 -13.4%
Other operating charges 640/8 €467 €488 +€21 +4.5%
Gross operating margin 9900 €586,978 €603,444 +€16,467 +2.8%
Operating profit (loss) 9901 €303,764 €272,596 -€31,169 -10.3%
Financial income 75/76B - €1,621 +€1,621
Recurring financial income 75 - €1,621 +€1,621
Financial charges 65/66B €10,350 €7,009 -€3,341 -32.3%
Recurring financial charges 65 €10,350 €7,009 -€3,341 -32.3%
Profit (loss) for the period before taxes 9903 €293,414 €267,208 -€26,207 -8.9%
Income taxes 67/77 €75,299 €69,149 -€6,150 -8.2%
Profit (loss) for the period 9904 €218,115 €198,059 -€20,056 -9.2%
Profit (loss) for the period to be appropriated 9905 €218,115 €198,059 -€20,056 -9.2%

Source: filed annual accounts (NBB), fiscal years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.